The Precision Oncology Market Industry was estimated to be worth USD 96.5 billion in 2022, with a projected growth to reach USD 200.9 billion by 2030. This represents a compound annual growth rate (CAGR) of 9.6% during the forecast period from 2023 to 2030.

Precision oncology, a rapidly expanding field, focuses on tailoring cancer treatment to individual patients based on their genetic makeup, lifestyle, and other factors. The market's significant growth can be attributed to advancements in genomic sequencing technologies, increasing awareness about personalized medicine, and the rising prevalence of cancer worldwide.

With the advent of precision oncology, healthcare providers can now offer targeted therapies that have the potential to improve patient outcomes and reduce adverse effects. By analyzing a patient's genetic profile, doctors can identify specific mutations or biomarkers that drive the growth of cancer cells. This enables them to select the most effective treatment options, such as targeted therapies, immunotherapies, or combination therapies, tailored to the individual's unique needs.

Furthermore, the growing adoption of precision oncology by pharmaceutical companies and research institutions has fueled the market's expansion. These entities are investing heavily in research and development to discover novel biomarkers and develop innovative therapies. Additionally, collaborations between academic institutions, healthcare providers, and pharmaceutical companies are driving the translation of precision oncology research into clinical practice.

Geographically, North America currently dominates the precision oncology market due to the presence of well-established healthcare infrastructure, high healthcare expenditure, and a strong focus on research and development. However, the Asia-Pacific region is expected to witness the highest growth rate during the forecast period. Factors such as a large patient population, increasing disposable income, and rising awareness about personalized medicine are contributing to the region's rapid market expansion.

In conclusion, the precision oncology market is poised for substantial growth in the coming years. The integration of advanced technologies, increasing collaborations, and a shift towards personalized medicine are driving factors behind this expansion

Get Sample Report @


By Product Type

  • Diagnostics
  • Therapeutics

By Cancer Type

  • Breast Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Prostate Cancer
  • Lung Cancer
  • Others

By End Use

  • Hospitals & Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Healthcare Data Companies

Key players

The major key players are Thermo Fisher Scientific Inc., Invitae Corporation, Qiagen N.V., Illumina, Inc., Laboratory Corporation of America Holding, Exact Sciences Corporation, Rain Oncology Inc., Strata Oncology, Inc., Xilis, Inc., Variantyx, Inc., Bioserve, Relay Therapeutics, Acrivon Therapeutics, and Others

Table of Contents  


2.Research Methodology

3.Market Dynamics

4.Impact Analysis

4.1COVID-19 Impact Analysis

4.2.Impact of Ukraine- Russia war

4.3.Impact of Ongoing Recession on Major Economies

5.Value Chain Analysis

6.Porter’s 5 Forces Model

7.PEST Analysis

8.Precision OncologyMarket, By   Product Type

9.Precision Oncology Market, By Cancer Type

10.Precision Oncology Market, By  End User

11.Regional Analysis

12.Company profile

13.Competitive Landscape

14.  Conclusion

Other Trending Report

Single-cell Omics Market Analysis 

Healthcare  Market Analysis

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:

Akash Anand – Head of Business Development & Strategy

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)